Exact Mass: 360.1056

Exact Mass Matches: 360.1056

Found 35 metabolites which its exact mass value is equals to given mass value 360.1056, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

6'-Methoxypolygoacetophenoside

1-(2,4-dihydroxy-6-methoxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethan-1-one

C15H20O10 (360.1056)


6-Methoxypolygoacetophenoside is a constituent of Crocus sativus (saffron) Constituent of Crocus sativus (saffron)

   

3-Methoxy-4-hydroxyphenylglycol glucuronide

(2S,3S,4S,5R,6S)-6-[4-(1,2-dihydroxyethyl)-2-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H20O10 (360.1056)


3-Methoxy-4-hydroxyphenylglycol (HMPG) glucuronide is the main form of HMPG in human urine. HMPG is a major metabolite of norepinephrine that is found in urine and cerebrospinal fluid (CSF). It has been determined that 25-50\\% of it is derived from brain norepinephrine. The conjugated form is reported to be derived mainly from the metabolism of systemic norepinephrine. (PMID 528605) [HMDB] 3-Methoxy-4-hydroxyphenylglycol (HMPG) glucuronide is the main form of HMPG in human urine. HMPG is a major metabolite of norepinephrine that is found in urine and cerebrospinal fluid (CSF). It has been determined that 25-50\\% of it is derived from brain norepinephrine. The conjugated form is reported to be derived mainly from the metabolism of systemic norepinephrine. (PMID 528605).

   

(2S,3S,4S,5R,6R)-3,4,5-Trihydroxy-6-[2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethoxy]oxane-2-carboxylic acid

(2S,3S,4S,5R,6R)-3,4,5-Trihydroxy-6-[2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethoxy]oxane-2-carboxylic acid

C15H20O10 (360.1056)


   

Glucosyringic acid

3,5-dimethoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoic acid

C15H20O10 (360.1056)


Glucosyringic acid, also known as glucosyringate, is a member of the class of compounds known as hydrolyzable tannins. Hydrolyzable tannins are tannins with a structure characterized by either of the following models. In model 1, the structure contains galloyl units (in some cases, shikimic acid units) are linked to diverse polyol carbohydrate-, catechin-, or triterpenoid units. In model 2, contains at least two galloyl units C-C coupled to each other, and do not contain a glycosidically linked catechin unit. Glucosyringic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Glucosyringic acid can be found in fennel, which makes glucosyringic acid a potential biomarker for the consumption of this food product.

   

Erigeside C

Syringic acid beta-glucopyranosyl ester

C15H20O10 (360.1056)


   

Glucosyringic acid

Syringin 4-O-beta-glucoside

C15H20O10 (360.1056)


   

MCULE-2357415168

MCULE-2357415168

C15H20O10 (360.1056)


   
   

ethyl O-beta-(6-galloyl)-glucopyranoside

ethyl O-beta-(6-galloyl)-glucopyranoside

C15H20O10 (360.1056)


   

Syringic acid-4-beta-D-glucopyranoside

Syringic acid-4-beta-D-glucopyranoside

C15H20O10 (360.1056)


   

4-methoxy-5-hydroxymethylbenzoic 3-O-beta-D-glucopyranoside

4-methoxy-5-hydroxymethylbenzoic 3-O-beta-D-glucopyranoside

C15H20O10 (360.1056)


   

methyl 4-O-beta-D-glucopyranosy-5-hydroxy-3-methoxylbenzoate

methyl 4-O-beta-D-glucopyranosy-5-hydroxy-3-methoxylbenzoate

C15H20O10 (360.1056)


   

3-(3,4-dihydroxyphenyl)-(2R)-lactic acid 4-O-beta-D-glucopyranoside|4-O-beta-D-Glucopyranoside-(R)-2-Hydroxy-3-(3,4-dihydroxyphenyl)propanoic acid

3-(3,4-dihydroxyphenyl)-(2R)-lactic acid 4-O-beta-D-glucopyranoside|4-O-beta-D-Glucopyranoside-(R)-2-Hydroxy-3-(3,4-dihydroxyphenyl)propanoic acid

C15H20O10 (360.1056)


   

SCHEMBL789290

SCHEMBL789290

C15H20O10 (360.1056)


   

Glucosyringicacid

3,5-dimethoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoic acid

C15H20O10 (360.1056)


Glucosyringic acid is a natural product found in Eupatorium chinense, Molineria crassifolia, and other organisms with data available.

   

[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3-hydroxy-4,5-dimethoxybenzoate

NCGC00381018-01![3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3-hydroxy-4,5-dimethoxybenzoate

C15H20O10 (360.1056)


   

[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3-hydroxy-4,5-dimethoxybenzoate

[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3-hydroxy-4,5-dimethoxybenzoate

C15H20O10 (360.1056)


   

Benzoic acid + 1O, 2MeO, O-Hex

Benzoic acid + 1O, 2MeO, O-Hex

C15H20O10 (360.1056)


Annotation level-3

   

[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3-hydroxy-4,5-dimethoxybenzoate [IIN-based: Match]

NCGC00381018-01![3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3-hydroxy-4,5-dimethoxybenzoate [IIN-based: Match]

C15H20O10 (360.1056)


   

[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3-hydroxy-4,5-dimethoxybenzoate_major

[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3-hydroxy-4,5-dimethoxybenzoate_major

C15H20O10 (360.1056)


   

3-Methoxy-4-hydroxyphenylglycol glucuronide

3-Methoxy-4-hydroxyphenylglycol glucuronide

C15H20O10 (360.1056)


   

6'-Methoxypolygoacetophenoside

1-(2,4-dihydroxy-6-methoxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethan-1-one

C15H20O10 (360.1056)


   

1-O-(3-Hydroxy-4,5-dimethoxybenzoyl)hexopyranose

1-O-(3-Hydroxy-4,5-dimethoxybenzoyl)hexopyranose

C15H20O10 (360.1056)


   

Haletazole

2-[4-(5-chloro-1,3-benzothiazol-2-yl)phenoxy]-N,N-diethylethanamine

C19H21ClN2OS (360.1063)


C254 - Anti-Infective Agent > C514 - Antifungal Agent

   
   

N-(4-fluorophenyl)-4-(4-nitrophenyl)-1-piperazinecarbothioamide

N-(4-fluorophenyl)-4-(4-nitrophenyl)-1-piperazinecarbothioamide

C17H17FN4O2S (360.1056)


   

1-[2,4-Dihydroxy-6-methoxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethanone

1-[2,4-Dihydroxy-6-methoxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethanone

C15H20O10 (360.1056)


   

VU0467485

VU0467485

C17H17FN4O2S (360.1056)


VU0467485 (AZ13713945) is a potent, selective, and orally bioavailable muscarinic acetylcholine receptor 4 (M4) positive allosteric modulator (PAM). VU0467485 (AZ13713945) potentiates activity of ACh at M4 with EC50s of 26.6 nM and 78.8 nM at rat and human M4 receptors, respectively. VU0467485 (AZ13713945) shows selectivity for M4 over human and rat M1/2/3/5. VU0467485 (AZ13713945) displays moderate to high CNS penetration. VU0467485 (AZ13713945) has antipsychotic-like activity[1].

   

1-(2,4-dihydroxy-6-methoxy-3-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethanone

1-(2,4-dihydroxy-6-methoxy-3-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethanone

C15H20O10 (360.1056)


   

(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 4-hydroxy-3,5-dimethoxybenzoate

(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 4-hydroxy-3,5-dimethoxybenzoate

C15H20O10 (360.1056)


   

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 4-hydroxy-3,5-dimethoxybenzoate

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 4-hydroxy-3,5-dimethoxybenzoate

C15H20O10 (360.1056)


   

(3r,4s,5r,6r)-3,4,5,6,7-pentahydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)heptane-1,2-dione

(3r,4s,5r,6r)-3,4,5,6,7-pentahydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)heptane-1,2-dione

C15H20O10 (360.1056)


   

methyl 3-hydroxy-4-methoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate

methyl 3-hydroxy-4-methoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate

C15H20O10 (360.1056)


   

3,5-dimethoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoic acid

3,5-dimethoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoic acid

C15H20O10 (360.1056)


   

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 4-hydroxy-3,5-dimethoxybenzoate

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 4-hydroxy-3,5-dimethoxybenzoate

C15H20O10 (360.1056)